Cargando…

HA117 gene increased the multidrug resistance of K562 cells in vitro: an investigation to the function of a novel gene related to drug resistance

OBJECTIVE: A novel multi-drug resistance gene named as HA117 has been screened and cloned in multidrug resisitant leukemia cell lines in our previous research, but its function is still unknown. In this study, HA117 gene was investigated whether it could increase the drug resistance in chronic myelo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yuxia, Zheng, Gaihuan, Jin, Xianqing, Xu, Youhua, Luo, Qing, Liu, Xiaomei, Zhao, Zhenzhen, Chen, Yong
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689865/ https://www.ncbi.nlm.nih.gov/pubmed/19435509 http://dx.doi.org/10.1186/1756-9966-28-63

Ejemplares similares

Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1
por: Zhao, Lihua, et al.
Publicado: (2010)

In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells
por: Zhou, Qianxiang, et al.
Publicado: (2016)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
por: WANG, LEI, et al.
Publicado: (2014)

Potential association of long noncoding RNA HA117 with tetralogy of Fallot
por: Wang, Quan, et al.
Publicado: (2018)

Proton NMR visible mobile lipid signals in sensitive and multidrug-resistant K562 cells are modulated by rafts
por: Mannechez, Aurélie, et al.
Publicado: (2005)

Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells
por: Zhang, Jian-Ye, et al.
Publicado: (2013)

Reversal of multidrug resistance by 5,5’-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX
por: Wang, Tian-Xiao, et al.
Publicado: (2013)

Establishment and molecular characterization of decitabine‐resistant K562 cells
por: Wen, Xiang‐Mei, et al.
Publicado: (2019)

HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6
por: Li, Shuangshuang, et al.
Publicado: (2017)

Characterization of an Etoposide‐resistant Human K562 Cell Line, K/eto
por: Sugawara, Isamu, et al.
Publicado: (1991)

Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line
por: Somno, Aoranit, et al.
Publicado: (2016)

Effect of magnetic nanoparticles of Fe(3)O(4) and wogonin on the reversal of multidrug resistance in K562/A02 cell line
por: Cheng, Jian, et al.
Publicado: (2012)

Genomic amplification of chromosome 7 in the Doxorubicin resistant K562 cell line
por: Ibrahim, Sara.M, et al.
Publicado: (2018)

Novel Palladium Complex: Cytotoxicity against Cisplatin-resistant K562 Cells
por: Jahanian-Najafabadi, Ali, et al.
Publicado: (2019)

Reversal in multidrug resistance by magnetic nanoparticle of Fe(3)O(4) loaded with adriamycin and tetrandrine in K562/A02 leukemic cells
por: Chen, Baoan, et al.
Publicado: (2008)

Effect of magnetic nanoparticles of Fe(3)O(4) and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
por: Cheng, Jian, et al.
Publicado: (2009)

Expression and clinical significance of multidrug resistance proteins in brain tumors
por: Guo, Zhenhua, et al.
Publicado: (2010)

Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo
por: Chen, Bao-an, et al.
Publicado: (2009)

Increase in the Level of P‐Glycoprotein mRNA Expression in Multidrug‐resistant K562 Cell Lines Treated with Sodium Butyrate Is Not Accompanied with Erythroid Differentiation
por: Shibata, Hiroyuki, et al.
Publicado: (1990)

Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1
por: Yi, Ying-Jie, et al.
Publicado: (2023)

Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies
por: Dechsupa, Nathupakorn, et al.
Publicado: (2023)

Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
por: Sargent, J M, et al.
Publicado: (2001)

Impairment of Methotrexate (MTX)‐Polyglutamate Formation of MTX‐resistant K562 Cell Lines
por: Koizumi, Shoichi
Publicado: (1988)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
por: Prado-Carrillo, Omar, et al.
Publicado: (2022)

Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells
por: Tan, Fang, et al.
Publicado: (2010)

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003)

Effects of Decitabine on the proliferation of K562 cells and the expression of DR4 gene
por: Zhang, Wenhui, et al.
Publicado: (2018)

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis
por: Wang, Wenjing, et al.
Publicado: (2019)

Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling
por: Yu, Jiang, et al.
Publicado: (2021)

Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice
por: Zhao, ZhenZhen, et al.
Publicado: (2010)

Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells.
por: Millot, J. M., et al.
Publicado: (1989)

Corrigendum to “Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis”
por: Wang, Wenjing, et al.
Publicado: (2021)

H-Ferritin-Regulated MicroRNAs Modulate Gene Expression in K562 Cells
por: Biamonte, Flavia, et al.
Publicado: (2015)

Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells
por: Dong, Yan, et al.
Publicado: (2017)

Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy
por: Li, Zhao, et al.
Publicado: (2020)

Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG
por: Lombardi, Giulia, et al.
Publicado: (2022)

Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991)

Detection approaches for multidrug resistance genes of leukemia
por: Du, Ying, et al.
Publicado: (2017)

Differential Gene Expression Analysis in K562 Human Leukemia Cell Line Treated with Benzene
por: Choi, Sulji, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sqqt1vdo7naveu61ga5622h5tf